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Abstract Hic-5 is a CAKL-binding protein localized at focal
adhesions. Here we show that overexpression of CAKL or Fyn,
but not FAK, enhanced the tyrosine phosphorylation of
coexpressed Hic-5 in COS-7 cells. These phosphorylations were
further augmented by stimulating cells with osmotic stress. The
Y60F mutant of Hic-5 was not phosphorylated, and Hic-5
phosphorylated on tyrosine 60 was bound specifically to the SH2
domain of Csk. Coexpression experiments revealed that the
phosphorylation of Hic-5 by CAKL required the kinase
activation of CAKL and binding of Hic-5 by CAKL. Specific
phosphorylation of Hic-5 by CAKL and Fyn may activate a
signaling pathway mediated by Hic-5.
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1. Introduction
We identi¢ed Hic-5 by expression cloning as a CAKL-bind-
ing protein [1]. Hic-5 cDNA was initially identi¢ed by Shiba-
numa et al. [2] as one of the cDNA clones derived from
mRNA induced by hydrogen peroxide. Hic-5 localizes at focal
adhesions in ¢broblasts [1]. In a rat ¢broblast line WFB,
which expresses CAKL and Hic-5 endogenously, Hic-5 and
CAKL are coimmunoprecipitated and Hic-5 is tyrosine
phosphorylated in parallel with CAKL when cells were stimu-
lated with osmotic stress [1]. Hic-5 is related to paxillin in
structure and these two proteins share four LD motifs and
four LIM domains [1]. One of the LD motifs mediates the
association of Hic-5 with CAKL, which, also called PYK2 [3],
RAFTK [4], CadTK [5], is a non-receptor protein tyrosine
kinase of the focal adhesion kinase (FAK) family. LIM do-
mains determine the localization of paxillin and Hic-5 at focal
adhesions [6^9]. Other proteins also associate to the LD mo-
tifs and the LIM domains [10^12]. Similarity in amino acid
sequence between Hic-5 and paxillin is not high outside the
LD and LIM regions and these two proteins probably have
distinct functions. There is no amino acid sequence in Hic-5
corresponding to the ligand sequences of paxillin where Crk
and Src bind with their SH2 or SH3 domain. Recently Hic-5
was shown to be a coactivator of nuclear receptors [13], sug-
gesting that Hic-5 has functions both in the cytoplasm and in
the nucleus. In this paper, we showed that Hic-5 was
phosphorylated at tyrosine 60 by CAKL and also by Fyn.
The phosphorylation by CAKL required the kinase activity
of CAKL, tyrosine residue 402, an Src-binding site of
CAKL, and the Hic-5-binding sites of CAKL. This phosphor-
ylation on tyrosine 60 created in Hic-5 a possible binding site
for the SH2 domain of Csk.
2. Materials and methods
2.1. Recombinant cDNAs
All the CAKL cDNA constructs used here originated from clone
17N, a full-length rat CAKL cDNA [14]. Construction of the deletion
mutant of paxillin-binding subdomain 1 (dl741^903) was described
previously [1]. To construct CAKL(Y402F) and CAKL(K457A),
site-directed mutations were introduced by using oligonucleotides
GAATCTCTGCAAAGATATCTGACTCTAT and CTTACAGGT-
CGCGACGGCCA. The former changed the coding sequence of ty-
rosine 402 to phenylalanine and the latter changed lysine 457 to ala-
nine. The construction of CAKL(CGM), in which proline residues 717
and 859 were changed to alanine, was previously described [15]. These
CAKL cDNA constructs were cut with BstUI and EcoRI and sub-
cloned into pcDNA3. CAKL fused to glutathione S-transferase
(GST), GST-CAKL, was expressed from pGEX-CAKL, which was
constructed by subcloning a BamHI/EcoRI fragment of pEBG-
CAKL [1] into pGEX-2T. GST-CAKL(Y402F) was constructed by
swapping the NsiI fragments, which cover the mutation site, between
pcDNA3-CAKL(Y402F) and pGEX-CAKL. For construction of the
expression vector of FAK, a BamHI site was introduced juxtaposed to
the translation initiation codon of a cDNA encoding full-length wild-
type mouse FAK [16], by using PCR primers CGGATCCATGG-
CAGCTGCTTATCTTGACC and CGCATATGACTGAGGCGAA-
ATCCATAG. The FAK cDNA was then inserted into the BamHI site
of pcDNA3Myc [1].
cDNA constructs for the expression of Hic-5 were derived from the
original human Hic-5 cDNA clone, cbp-1 [1], to which ATG was
added at its 5P end. This ATG was assigned as the ¢rst methionine
codon of Hic-5 according to Thomas et al. [8]. Addition of the ¢rst
methionine codon to cbp-1 was done by PCR using the forward prim-
er GTCTAGACAGACCGTGCATCATGGAGGACCTGGATGCC-
CTG, which was designed to introduce the XbaI site at the 5P termi-
nus. The construct was cut with XbaI and EcoRI and subcloned into
XbaI/EcoRI-digested pcDNA3.1(3) to make pcDNA3-Hic-5. Y60F
mutation of Hic-5 was introduced by site-directed mutagenesis using
an oligonucleotide, CATACCGTGCTGAACAGGTGGTCC. Oligo-
nucleotide site-directed mutagenesis was done by the Kunkel method
[17] by the use of a Mutan-K mutagenesis kit (Takara). The mutation
and ¢delity of DNA ampli¢cation by PCR were con¢rmed by DNA
sequencing. Fyn expression vector ME18S-Fyn was a kind gift of T.
Yamamoto [18]. Vectors expressing GST fusion proteins of Csk-SH2
[19], Crk-I-SH2 [20], and GST-Fyn-SH2 and GST-Src-SH2 [21] were
generously provided by M. Okada, M. Matsuda, and S. Kobayashi,
respectively.
2.2. Antibodies
Preparation of rabbit serum against CAKL residues 670^716 (anti-
CAKL(C-a), designated anti-CAKL(C) in this paper) and rabbit se-
rum against the CAKL N-terminal region, anti-CAKL(N), were as
described [1]. A mixture of anti-CAKL(N) and anti-CAKL(C) was
used for Western blotting. Production of the a⁄nity puri¢ed rabbit
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anti-Hic-5 antibody, anti-Hic-5, was described previously [1]. Anti-
GST was derived from rabbit serum against GST-Hic-5, from which
the anti-GST fraction was isolated by using GST coupled to CNBr-
activated Sepharose beads. Monoclonal antibodies against phospho-
tyrosine (4G10, mouse IgG2) and paxillin (clone 349, mouse IgG1)
were purchased from Upstate Biotechnology, Inc. and Transduction
Laboratories, respectively. The Fyn polyclonal antibody against the
N-terminal region of Fyn was previously described [22]. Fyn mono-
clonal antibody (Fyn(15)) was a product of Santa Cruz Biotechnol-
ogy, Inc. Anti-phosphotyrosine (PT66) conjugated agarose beads were
purchased from Sigma.
2.3. Expression of cDNA constructs in COS-7 cells, and
cell stimulation with osmotic stress
COS-7 cells were grown in a culture medium (Iscove’s modi¢ed
Dulbecco’s medium supplemented with 10% heat-inactivated fetal
calf serum, 2 mM glutamine, 1 mM sodium pyruvate, 50 units/ml
penicillin and 50 Wg/ml streptomycin). COS-7 cells growing close to
con£uence in 10 cm culture dishes were transfected with up to 10 Wg
of expression plasmid constructs as speci¢ed in the legends using
DEAE-dextran and used 48 to 70 h after the transfection. Where
indicated, cells were stimulated with osmotic stress by exposing
them to 0.3 M sorbitol in culture medium at 37‡C for 8 min before
cell lysis.
2.4. Recombinant adenovirus
The XbaI-EcoRI fragment of pcDNA3-Hic-5 containing the entire
coding sequence was blunted and inserted into the SwaI site of the
adenovirus cosmid cassette, pAxCAwt [23]. A recombinant adenovi-
rus for expression of Hic-5, AxCASHic5, was obtained by transfecting
293 cells with the above cosmid together with adenoviral DNA cut
with EcoT22I, according to the COS-TPC method [24]. For infection
with AxCASHic5, the medium was removed from rat 3Y1 cells grow-
ing at 70% con£uence in 10 cm dishes and the cells were infected with
AxCASHic5 in 1 ml of culture medium at a moi of 10. The cells were
supplied with 10 ml of culture medium 1 h after infection, and used
2 days later.
2.5. Immunoprecipitation and immunoblotting
Cells were lysed in RIPA bu¡er (1% sodium deoxycholate, 0.1%
sodium dodecyl sulfate, 1% NP40, 25 mM HEPES pH 7.2, 150 mM
NaCl, 1 mM EDTA, 0.3 mg/ml benzamidine, 1 Wg/ml leupeptin, 10
Wg/ml aprotinin, 0.1 mg/ml soybean tripsin inhibitor, 1 mM phenyl-
methylsulfonyl £uoride, 50 mM NaF, and 1.5 mM Na3VO4). This
RIPA bu¡er dissociates binding between Hic-5 and CAKL [1]. Cell
lysates were incubated with the antiserum speci¢ed and with 10 Wl of
protein A-Sepharose beads for 4 h or more up to overnight. The
antisera used for the immunoprecipitation of CAKL and Hic-5 were
anti-CAKL(N) and anti-Hic-5, respectively. After three washes with
the bu¡er used in the lysis of cells, bound proteins were eluted with
sample bu¡er for SDS^polyacrylamide gel electrophoresis (PAGE) at
90‡C for 5 min, and analyzed by SDS^PAGE in 10% gels. The sep-
arated proteins were transferred to polyvinylidene di£uoride (PVDF)
membranes (Immobilon-P, Millipore). The membranes were blocked
with 3% bovine serum albumin (BSA) in TBST (25 mM Tris, pH 7.6,
136 mM NaCl, 0.1% Tween-20) at 60‡C for 20 min and incubated at
room temperature for 2 h in TBST containing the speci¢ed antibody
and 1% BSA. The membranes were then washed three times in TBST,
incubated at room temperature for 1 h in TBST containing goat anti-
mouse (Kirkegaard and Perry Laboratories, MD, USA) or goat anti-
rabbit (Sigma) antibodies conjugated with horseradish peroxidase,
and ¢nally washed three times in TBST. The peroxidase conjugated
antibodies were then located by chemiluminescence (ECL, Amersham
Corp.).
3. Results
3.1. Tyrosine phosphorylation of Hic-5 by Fyn and CAKL
We previously showed that the tyrosine phosphorylation of
Hic-5 was enhanced in parallel with that of CAKL when rat
WFB ¢broblasts, which express these proteins endogenously,
were serum-starved and then stimulated with lysophosphatidic
acid or exposed to high-osmotic stress to activate CAKL [1].
COS-7 cells were doubly transfected with two di¡erent expres-
sion vectors, one encoding Hic-5 and the other coding one of
the non-receptor tyrosine kinases; Fyn, FAK, or CAKL. Co-
expression of CAKL, but not of FAK, with Hic-5 resulted in
the tyrosine phosphorylation of Hic-5 (Fig. 1A, lanes 5 and
7). In agreement with our previous observation in WFB cells,
the phosphorylation by CAKL was further enhanced by treat-
ing the cells with high-osmotic stress (lane 8). Interestingly,
Fyn also increased the phosphorylation of Hic-5 (lane 3).
Moreover, this phosphorylation was also enhanced by the
Fig. 1. Phosphorylation of Hic-5 on tyrosine 60 by CAKL and Fyn.
A: COS-7 cells were transiently transfected with pcDNA-Hic-5
(Hic-5), together with an empty expression plasmid (3, lanes 1, 2)
or an expression plasmid of Fyn (lanes 3, 4), FAK (lanes 5, 6) or
CAKL (lanes 7, 8) as indicated. After 2 days of culture, cells were
lysed directly (OS 3) or after they were stimulated by osmotic stress
(OS +). Aliquots of the cell lysates were taken aside to monitor the
expression of introduced kinases; the expression of Fyn was deter-
mined after immunoprecipitation and CAKL and FAK were deter-
mined without immunoprecipitation. The remaining extracts were
subjected to immunoprecipitation with anti-Hic-5. Immunoprecipi-
tates and the total cell extracts were analyzed by immunoblotting
with anti-phosphotyrosine (PY), anti-Fyn, anti-FAK, and anti-
CAKL antibodies. Hic-5 immunoprecipitates were probed with anti-
PY and then probed again with anti-Hic-5 after the bound antibody
was stripped o¡. B: COS-7 cells were doubly transfected with two
di¡erent expression plasmids, one for expression of Hic-5, either the
wild-type (wt) or Y60F mutant (Y60F), and the other, either an
empty expression plasmid (3) or an expression plasmid of CAKL
or Fyn as indicated. After 2 days of culture, the cells were stimu-
lated with osmotic stress and then lysed. Lysates were analyzed by
immunoblotting as described in A.
FEBS 23725 25-5-00
M. Ishino et al./FEBS Letters 474 (2000) 179^183180
osmotic stress (lane 4). The percentages of Hic-5 phosphory-
lated by CAKL and Fyn were determined by comparing the
amount of Hic-5 precipitated by anti-phosphotyrosine anti-
body with the total amount of Hic-5. In a rough estimation
on Hic-5 from cells exposed to osmotic stress, 4% and 16% of
Hic-5 present in a cell were found to be tyrosine phosphory-
lated when CAKL and Fyn, respectively, were coexpressed.
When these kinases were not coexpressed, the tyrosine phos-
phorylation of Hic-5 was not detectable.
3.2. Phosphorylation of Hic-5 at tyrosine 60
Although the structure of Hic-5 is similar to that of paxillin
in the alignment of domains and in the amino acid sequences
of LIM domains and LD motifs, there are no sequences on
Hic-5 corresponding to two major phosphorylation sites
known in paxillin, tyrosine residues 31 and 118 [25,26]. There
is, however, one tyrosine at residue 60 in the N-terminal re-
gion of Hic-5, which has preceding aspartic acid residues and
is likely to be phosphorylated by protein tyrosine kinases. We
prepared a Hic-5 mutant (Y60F) in which this tyrosine residue
was changed to phenylalanine. COS-7 cells were doubly trans-
fected with two di¡erent plasmid vectors, one encoding either
CAKL or Fyn and the other encoding either wild-type Hic-5
or the Y60F mutant of Hic-5. The wild-type Hic-5 was found
to be tyrosine phosphorylated when coexpressed with CAKL
or Fyn, but Y60F Hic-5 was hardly phosphorylated under the
same conditions (Fig. 1B), indicating that tyrosine 60 was the
major site of Hic-5 phosphorylation.
3.3. Speci¢c binding of the SH2 domain of Csk to
phosphorylated Hic-5
One of the major consequences of tyrosine phosphorylation
of signaling proteins is the formation of a speci¢c binding site
to the SH2 domain of a ligand molecule. We examined GST
fusion proteins of the SH2 domains from Crk, Fyn, Src and
Csk, to determine their ability to bind the tyrosine phosphor-
ylated Hic-5. Rat 3Y1 cells were infected with a Hic-5-express-
ing recombinant adenovirus, treated with pervanadate and
then lysed to use in the a⁄nity-binding experiment. We found
that the phosphorylated Hic-5 present in the 3Y1 cell lysate
was bound speci¢cally to the Csk SH2 domain (Fig. 2A, top
panel). The amount of Hic-5 bound to the Csk SH2 was 200
times higher than the amount bound to the Crk SH2. In
contrast to Hic-5, paxillin endogenously present in the perva-
nate-treated cells was bound to the SH2 domains of both Crk
and Csk (Fig. 2A, middle panel). To prove that the phosphor-
ylation of tyrosine 60 creates the site for this association with
the Csk SH2 domain, lysates of COS-7 cells overexpressing
both CAKL and Hic-5, either wild-type or the Y60F mutant,
were subjected to a⁄nity precipitation with the GST-Csk SH2
domain. As expected, wild-type Hic-5 was pulled down with
the GST-Csk SH2 domain and Hic-5(Y60F) was not (Fig.
Fig. 2. Phosphorylation of Hic-5 on tyrosine 60, which on phos-
phorylation was bound with speci¢city to Csk-SH2. A: 3Y1 cells in-
fected with a recombinant adenovirus encoding Hic-5 were treated
with 0.5 mM pervanadate for 10 min and then the cells were lysed.
Cell lysate was incubated at 4‡C for 4 h with GST (3), GST-Crk-
SH2 (Crk), GST-Fyn-SH2 (Fyn), GST-Src-SH2 (Src), and GST-
Csk-SH2 (Csk) along with glutathione-Sepharose beads. As a con-
trol, the same amount of the lysate was immunoprecipitated with
anti-Hic-5. Relative intensities of the signals were given under the
photo. Bound proteins were analyzed by immunoblotting with anti-
Hic-5 and with anti-GST antibodies. The Hic-5 blot was probed
again with anti-paxillin after the bound antibody was stripped o¡.
B: COS-7 cells were transfected with two di¡erent plasmids, one en-
coding Hic-5, either wild-type (wt) or Y60F mutant (Y60F), or an
empty vector (3), and the other encoding CAKL (+) or an empty
vector. After cell stimulation by osmotic stress, lysates were pre-
pared and subjected ¢rst to a⁄nity precipitation (AP) with GST-
Csk-SH2. Then, Hic-5 was immunoprecipitated (ip) from the super-
natant obtained on the a⁄nity precipitation assay. Proteins bound
to GST-Csk-SH2 and anti-Hic-5 were analyzed by immunoblotting
with anti-Hic-5 antibody.
Fig. 3. Phosphorylation of Hic-5 by CAKL mutants. COS-7 cells
were transfected with two di¡erent expression plasmids, one encod-
ing Hic-5 (+) or an empty vector (3), and the other encoding
CAKL (wt), CAKL(Y402F), CAKL(K457A), or CAKL(dl741^903),
or an empty vector. Three days after the transfection, cells were
stimulated by osmotic stress and lysed. An aliquot of the lysates
was used to monitor the expression of CAKL. The other lysate was
subjected to immunoprecipitation with anti-Hic-5. The cell lysates
and the immunoprecipitates were analyzed by immunoblotting with
anti-CAKL and anti-phosphotyrosine antibodies, respectively. Hic-5
immunoprecipitates were then probed with anti-Hic-5 after the
bound anti-PY antibody was stripped o¡.
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2B). In the control cells where CAKL was not expressed, Hic-
5 was not pulled down with the GST-Csk SH2 domain. The
cell biological importance of this Hic-5-Csk association is still
not clear because we were not able to show coimmunopreci-
pitation of Csk with Hic-5 in lysates from cells and tissues.
However, the results shown in Fig. 2 indicate that the Hic-5
phosphorylated at tyrosine 60 binds to certain SH2 domain(s)
with high speci¢city.
3.4. Phosphorylation of Hic-5 by mutant forms of CAKL
We tried to answer the question whether the phosphory-
lation of Hic-5 required direct binding of Hic-5 to CAKL.
COS-7 cells were doubly transfected with the vector encoding
Hic-5 along with the vector encoding wild-type or mutant
CAKL. The cells were stimulated by osmotic stress and lysed,
and then the phosphorylation of Hic-5 was assayed by West-
ern blotting. As shown in Fig. 3, Hic-5 was not phosphory-
lated when coexpressed with CAKL(K457A), CAKL(Y402F),
or CAKL(dl741^903); these are a kinase-minus mutant, an
Src-binding site mutant [27], and a deletion mutant of a pax-
illin-binding site, which was previously shown to be defective
in the association with Hic-5 [1], respectively. Importantly,
CAKL(Y402F) is not functional as a kinase on Hic-5. The
data suggest that the activation of CAKL kinase and direct
association of CAKL with Hic-5 were both necessary for the
phosphorylation of Hic-5. On the other hand, we were not
able to detect by Western blot analysis any coprecipitation of
Hic-5 with Fyn and of Fyn with Hic-5 in overexpression sys-
tem of COS-7 cells (data not shown).
4. Discussion
We previously showed that in WFB cells, which express
CAKL and Hic-5 endogenously, the level of Hic-5 tyrosine
phosphorylation was increased when cells were exposed to
high-osmotic stress which activates CAKL [1]. COS-7 cells
do not endogenously express Hic-5 at a detectable level.
When exogenously expressed alone, Hic-5 was not tyrosine
phosphorylated even after stimulation by osmotic stress,
although COS-7 cells endogenously express c-Src and FAK.
The tyrosine phosphorylation of Hic-5 expressed in COS-7
cells was markedly enhanced by coexpression of Fyn or
CAKL, but not by coexpression of FAK. These results indi-
cated the presence of an intracellular signaling pathway trig-
gered by mechanical stress on a cell, leading to the phosphor-
ylation of Hic-5 by Fyn and/or CAKL. Although we have
already shown that CAKL binds directly to Hic-5 [1], there
is no report so far describing an osmosensor that couples to
the CAKL activation. Recently, Fyn, but not Src, was shown
to increase tyrosine phosphorylation of cortactin in CHO cells
upon osmotic stress [28]. If some Src family kinase is activated
in COS-7 cells at the downstream of mechanical stress, CAKL
can possibly be activated by the Src family kinase. Activated
Src family kinase also helps to maintain the activated state of
CAKL by binding to CAKL at the phosphorylated tyrosine
402 [29,30] and thus protecting the phosphoryl residue from
the attack of phosphatases. On the other hand, transient ex-
pression of exogenous Hic-5 and Fyn in COS-7 cells also
resulted in the phosphorylation of Hic-5 in the absence of
CAKL expression. This result indicated that Fyn could phos-
phorylate Hic-5 without a help of CAKL. However, we were
not able to show an association of Fyn with Hic-5 in the
coexpressed cells. It is known that Hic-5 does not have a
binding site for Src-SH3 which is present in paxillin. There-
fore, it cannot be excluded as a possibility that overexpressed
Fyn phosphorylated Hic-5 non-speci¢cally. However, because
Hic-5 was phosphorylated more e¡ectively in Fyn expressing
cells as compared with cells expressing CAKL, there could be
some functional connection between Fyn and Hic-5. Fyn,
though not binding directly to Hic-5, may associate with
Hic-5 possibly through endogenous CAKL which did exist
in COS-7 cells in barely detectable level, or through some
adapter protein(s) yet remains to be characterized.
Many of the downstream signaling pathways well known to
be activated by FAK are also set in motion once CAKL is
activated. However, the upstream signaling pathways linked
to CAKL activation are still largely unknown. Although
CAKL is activated, like FAK, following stimulation of recep-
tors coupled to phospholipase C activation, only a few up-
stream pathways unique to CAKL have been reported. These
are the activation of CAKL in the downstream of Fyn, JAK3,
and Syk following stimulation of immunoreceptors and cyto-
kine receptors [31^33]. Osmotic stress most e¡ectively stimu-
lates CAKL in many cultured cells. Although FAK is also
found to associate with Hic-5, either FAK overexpression or
stimulation of FAK by ligating integrin, or by osmotic stress
does not increase Hic-5 phosphorylation ([34] and data not
shown). Phosphorylation of Hic-5 may thus be speci¢c to
CAKL activation. Although Hic-5 localizes at focal adhesions
in ¢broblasts [1], CAKL is generally found di¡usely distrib-
uted throughout the cytoplasm [1,35,36]. The intracellular site
of the Hic-5 phosphorylation is thus unclear. However, the C-
terminal non-catalytic domain of CAKL expressed as a frag-
ment was found to localize exclusively at focal adhesions [35],
indicating a possible function of CAKL at focal adhesions on
some special, controlled occasions. It is also possible that
CAKL phosphorylates Hic-5 in some other compartments of
the cell, such as the nucleus.
Tyrosine phosphorylation of signaling proteins often gener-
ates a speci¢c binding site to a modular protein domain me-
diating protein assembly, such as SH2 and PTB domains. Our
data indicate a possibility that Csk binds the phosphorylated
Hic-5 with its SH2 domain. This implies that a negative feed-
back loop of CAKL activation is formed: Csk can inactivate
Src family kinases associated with CAKL, leading to the dis-
sociation of Src family kinases from CAKL and then to the
exposure of the phosphorylated tyrosine 402 to phosphatases,
such as PTP-PEST [10]. However, we have not so far suc-
ceeded in proving an in vivo association of Csk with Hic-5.
Indeed, the amount of Hic-5 pulled down with GST-Csk SH2
was not very high. Although weaker binding does not neces-
sarily mean that the association is not functioning within cells,
the results may imply possible presence of another protein(s)
that endogenously interact with the tyrosine phosphorylation
site of Hic-5. However, a demonstration of a speci¢c interac-
tion of tyrosine phosphorylated Hic-5 with some SH2 do-
mains, in this case Csk SH2, is by itself important because
the intracellular signaling through tyrosine phosphorylation
relies on speci¢c protein^protein interactions. Indeed, the
binding between the Csk SH2 and tyrosine phosphorylated
Hic-5 was shown to be speci¢c, suggesting a function of this
phosphorylated site in some intracellular signaling pathway.
Proteins other than Csk that bind to Hic-5 at the site of
phosphorylated tyrosine 60 are now in search to be found.
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